Skip to main content
. 2019 Aug 28;12:1527–1541. doi: 10.2147/DMSO.S202193

Table 4.

Multivariable odds ratio of clinical factors for LADA and classic T1DM in Chinese patients with newly diagnosed diabetes

LADA Classic T1DM
OR (95%CI) p-Value OR (95%CI) p-Value
Age, years 0.0219* <0.0001*
 30–39 vs ≥50 1.32(1.02–1.71) 3.51(2.53–4.89)
 40–49 vs ≥50 1.16(0.93–1.44) 1.35(0.95–1.90)
BMI 0.0069* 0.0007*
 Overweight 0.74(0.59–0.94) 0.52(0.36–0.79)
 Obesity 0.66(0.45–0.98) 0.40(0.19–0.88)
 Normal weight 1.0 1.0
Central obesity 0.84(0.66–1.05) 0.1239 1.10(0.76–1.60) 0.6025
Family history of diabetes 0.80(0.65–1.00) 0.0463 0.74(0.54–1.03) 0.0709
BP <130/80 mmHg 1.32(1.09–1.60) 0.0045 1.16(0.88–1.54) 0.2849
LDL-C <2.6 mmol/L 1.07(0.88–1.29) 0.4978 1.35(1.02–1.78) 0.0341
TG <1.7 mmol/L 1.48(1.21–1.81) 0.0002 1.26(0.92–1.73) 0.1462
HDL-C >1.0 mmol/L in male or 1.3 mmol/L in female 1.15(0.95–1.40) 0.1555 0.94(0.70–1.25) 0.6586
HbA1c <7.0% (53 mmol/mol) 0.82(0.63–1.07) 0.1375 1.09(0.70–1.71) 0.6919
Fasting C-peptide 0.0010* <0.0001*
 Upper quartile 0.66(0.52–0.85) 0.10(0.05–0.18)
 Mid-high quartile 0.68(0.50–0.93) 0.11(0.04–0.28)
 Mid-low quartile 0.57(0.39–0.85) 0.09(0.02–0.43)
 Bottom quartile 1.0 1.0
Postprandial C-peptide <0.0001* <0.0001*
 Upper quartile 0.42(0.32–0.54) 0.13(0.08–0.23)
 Mid-high quartile 0.38(0.28–0.52) 0.03(0.01–0.13)
 Mid-low quartile 0.45(0.31–0.66) 0.09(0.02–0.35)
 Bottom quartile 1.0 1.0
Lifestyle
 Current drinking 0.75(0.57–0.98) 0.0336 0.94(0.65–1.35) 0.7187
Use of drugs
 Antihypertensive drugs 0.91(0.70–1.19) 0.4916 0.68(0.41–1.14) 0.1432
 Lipid lowering drugs 0.63(0.43–0.91) 0.0131 0.90(0.54–1.53) 0.7026
 Insulin 1.79(1.38–2.32) <0.0001 3.60(2.65–4.89) <0.0001
 Alpha-glucosidase inhibitor 1.41(1.13–1.76) 0.0025 1.21(0.85–1.73) 0.2933
 Metformin 0.99(0.81–1.21) 0.9285 0.58(0.41–0.83) 0.0025
 Sulphonylurea 1.12(0.86–1.47) 0.4035 0.57(0.32–1.03) 0.0613

Note: *p for trend.

Abbreviations: LADA, latent autoimmune diabetes of adults; T1DM, type 1 diabetes mellitus; OR, odds ratio; GLP-1, glucagon-like peptide-1.